Startup Higo Sense Scores €5M To Further Global Expansion

WARSAW-BASED HEALTHTECH STARTUP HIGO SENSE SCORES €5 MILLION TO DOUBLE DOWN ON GLOBAL EXPANSION

Startup Higo Sense
Image Credit: Higo Sense

Startup Higo Sense, a Warsaw-based digital healthcare provider has just announced a €5 million Series A funding round backed by Cogito Capital Partners, the round also saw the participation of early-stage investors, the founder of RTB House.

The healthtech startup which was founded in 2017 offers a mobile medical examination device that is enabled by a mobile app coupled with an online AI-powered health diagnostic platform. However, the subject company is designed to enable physicians to carry out high-quality remote patient examinations in addition to patients performing a self-examination, as well as collect diagnostic data prior to or during a telehealth session.

Equally, the startup’s device is believed to be a modular examination tool consisting of a primary device that includes five extension modules, each is assigned to different functions: thermometer, throat spatula, stethoscope, otoscope, and derm hood, enabling both patients and doctors to remotely examine body temperature, throat, lungs, heart, skin, and ears.

As a result, patients and doctors are guided accordingly through the step-by-step medical examination via the mobile app coupled with the fact that they can also have access to their health records, should they opt-in – this will make telehealth safe, secure, and easy to operate.

It’s also worth noting that in the midst of a global health crisis complicated by the current pandemic have seen the telemedicine market experience massive growth as patients and doctors have increasingly turned to technology for routine medical consultations like Higo Sense. Which uses AI-enabled algorithms to drive its platform and through enabling a comprehensive and guided remote examination, which, to this end, startup Higo Sense is believed to have significantly expanded the range of conditions and symptoms that can now be effectively diagnosed during a telehealth session, ClinchBase have learnt from a source familiar with the matter.

Responding to the platform’s efficacy, ‘Lukasz Krasnopolski’, the CEO and founder of Higo Sense said: “At Higo, our mission is to deliver both, enhanced patient experience and improved efficiency for healthcare providers. With Higo device and AI-powered health diagnostic platform, we enable a remote examination that combines the advantages of telehealth session and in-person appointment”.

Moreover, since the inception of the subject company, the startup has successfully secured €8 million while launching its medical device across Europe. While further on this, the latest funding injection will be used to help the startup double down on its expansion across Europe, Asia, and the Middle East.

  • What’s your take on this development?